Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Pathology|January 1, 2014
The changing face of GIST: implications for pathologistsChris Hemmings, Desmond YipPathology|May 1, 2009
Immunohistochemical expression of EGFR in colorectal carcinoma correlates with high but not low level gene amplification, as demonstrated by CISHChris Hemmings, Amy Broomfield, Elaine Bean, et al.Pathology|April 19, 2013
Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesisChris HemmingsPathology|January 21, 2010
The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesisChris HemmingsCancer Medicine|November 7, 2020
Characteristics and risk factors for microbial infections during cancer immune checkpoint therapyYada Kanjanapan, Desmond YipPathology|August 18, 2020
Pathological assessment of tumour regression following neoadjuvant therapy in pancreatic carcinomaChris Hemmings, Saxon ConnorCancer Treatment Reviews|August 25, 2004
Recent advances in management of small-cell lung cancerYu Jo Chua, Christopher Steer, Desmond YipWorld Journal of Gastroenterology|July 1, 2014
Personalising pancreas cancer treatment: When tissue is the issueKatrin M Sjoquist, Venessa T Chin, Lorraine A Chantrill, et al.Clinical Trials (London, England)|August 20, 2014
How well informed is the informed consent for cancer clinical trials?Laeeq Malik, James Kuo, Desmond Yip, et al.World Journal of Hepatology|October 11, 2021
Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practiceAnkit Jain, Shivakumar Chitturi, Geoffrey Peters, et al.Pageof 12